Literature DB >> 14656471

Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.

Soazik P Jamin1, Nelson A Arango, Yuji Mishina, Mark C Hanks, Richard R Behringer.   

Abstract

Anti-Müllerian hormone (AMH)/Müllerian-inhibiting substance (MIS) is a member of the transforming growth factor-beta (TGF-beta) superfamily. Like other TGF-beta family members, AMH is likely to signal through two transmembrane serine/threonine kinase receptors. Whereas the AMH type II receptor has been clearly defined, only recently has there been evidence about the identity of the AMH type I receptor for Müllerian duct regression in vivo. We generated a new cre mouse line expressing the recombinase in AMH target cells. This line was then used to conditionally inactivate the Bmpr1a gene in the Müllerian duct, resulting in males with a uterus. Thus, Bmpr1a plays an essential role in the process of Müllerian duct regression. To investigate the role of Bmpr1a in granulosa cells, we took advantage of transgenic mice overexpressing human AMH. Surprisingly, these transgenic females that were also conditionally mutant for Bmpr1a in the Müllerian duct had no uterus. These results suggest that when AMH is overexpressed, other TGF-beta family type I receptors can potentially transduce AMH signals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656471     DOI: 10.1016/j.mce.2003.09.006

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  26 in total

1.  The potential role of microRNAs in regulating gonadal sex differentiation in the chicken embryo.

Authors:  Andrew D Cutting; Stephanie C Bannister; Tim J Doran; Andrew H Sinclair; Mark V L Tizard; Craig A Smith
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

2.  Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance.

Authors:  Elizabeth J Renaud; David T MacLaughlin; Esther Oliva; Bo R Rueda; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

3.  Genetic analyses reveal a requirement for Dicer1 in the mouse urogenital tract.

Authors:  Laura M Pastorelli; Sara Wells; Martin Fray; Adrian Smith; Tertius Hough; Brian D Harfe; Michael T McManus; Lee Smith; Adrian S Woolf; Michael Cheeseman; Andy Greenfield
Journal:  Mamm Genome       Date:  2009-01-24       Impact factor: 2.957

4.  Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.

Authors:  Ying Wang; Kathy Qi Cai; Elizabeth R Smith; Toni M Yeasky; Robert Moore; Parvin Ganjei-Azar; Andres J Klein-Szanto; Andrew K Godwin; Thomas C Hamilton; Xiang-Xi Xu
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

5.  Conditional gene recombination by adenovirus-driven Cre in the mouse uterus.

Authors:  Haibin Wang; Huirong Xie; Hao Zhang; Sanjoy K Das; Sudhansu K Dey
Journal:  Genesis       Date:  2006-02       Impact factor: 2.487

6.  Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.

Authors:  Xiufeng Wu; Ningning Zhang; Mary M Lee
Journal:  Endocrinology       Date:  2012-08-07       Impact factor: 4.736

7.  Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation.

Authors:  Jinjiang Fan; Enrico Campioli; Andrew Midzak; Martine Culty; Vassilios Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

8.  Extragonadal FSH receptor: is it real?

Authors:  T Rajendra Kumar
Journal:  Biol Reprod       Date:  2014-08-20       Impact factor: 4.285

9.  Lhx1 is required in Müllerian duct epithelium for uterine development.

Authors:  Cheng-Chiu Huang; Grant D Orvis; Kin Ming Kwan; Richard R Behringer
Journal:  Dev Biol       Date:  2014-02-21       Impact factor: 3.582

10.  MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing.

Authors:  Claudia V Andreu-Vieyra; Ruihong Chen; Julio E Agno; Stefan Glaser; Konstantinos Anastassiadis; A Francis Stewart; Martin M Matzuk
Journal:  PLoS Biol       Date:  2010-08-17       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.